维普中文期刊产品整合服务
76篇 您的检索式:作者名="RIBICHINI F"
    题名 作者 年代 出处 被引量
1经皮冠脉介入术后口服大剂量与小剂量泼尼松预防再狭窄疗效与安全性比较显示文摘据报道,口服大剂量泼尼松能有效降低经皮冠脉介入术(PCI)后的近期主要心脏事件风险。本文旨在就接受金属裸支架治疗的多支冠脉病变者PCI后,服用小剂量与大剂量泼尼松,对其术后主、次要临床事件的防治药效及安全性进行了对照分析。Ferrero V Ribichini F Rognoni A 袁志敏(摘译) 刘运德(校) 2008心血管病学进展2008,29,B05:2
2Clini- cal outcome after endovascuIar, surgical or hy- brid revascularisation in patients with com- bined carotid and coronary artery disease:the Finalised Research In ENDovascular Strategies Study Group ( FRIENDS ) 显示文摘Ribichini F Tomai F Reimers B 2010EuroInterven- tion2010,6,3:1
3Comparison of frequency of insulin resistance after coronary stenting in patients with type 2 diabetes mellitus with versus without coronary restenosis显示文摘Feola M Ribichini F Ferrero V 2004Am J Cardiol2004,94,6:1
4Estrogen eceptor-alpha polymorphisms and angiographic outcome after coronary artery tenting显示文摘Ferrero V Ribichini F Matullo G 2003Arterioscler Thromb Vasc Bioi2003,23,12:1
5Comparison of frequency of insulin resistance after coronary stenting in patients with type 2 diabetes mellitus with versus without coronary restenosis显示文摘FEOLA M RIBICHINI F FERRERO V 2004Am J Cardiol2004,94,6:1
6Plasma lipoprotein (a) is not a predictor for restenosis after elective high-pressure coronary stenting显示文摘RIBICHINI F STEFFENINO G DELLAVALLE A 1998Circulation1998,98,12:1
7Effect of angiotensinconverting enzyme inhibition on restenosis after coronary stenting 显示文摘Ribichini F Wijns W Ferrero V 2003Am J Cardiol2003,91,2:1
8Randomized com- parison of xiencev and multi-link vision coronary stents in the same multivessel patient with chronic kidney disease (RENAL-DES) study显示文摘Tomai F Ribichini F De Luca L 2014Circulation2014,129,10:1
9Em'ly creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography 显示文摘Ribichini F Graziani M Gambaro G 2010Am J Med2010,123,8:1
10A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery dis- ease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease) 显示文摘Ribichini F Romano M Rosiello R 2013JACC Cardiovasc Interv2013,6,10:1
11Plasma lipopro rein(a) is not a predictor for restenosis aiter elective high-pressure coronary stenting显示文摘Ribichini F Steffenino G Dellavalle A 1998Circulation1998,98,3:1
12Estrogen receptor- alpha polymorphisms and angiographic outcome after coronary artery stenting 显示文摘Ferrero V Ribichini F Matullo G 2008Arterioscler Thromb Vasc Biol2008,23,:1
13The diagnosis of coronary artery disease in hypertensive patients with chest pain and complete left bundle branch block:utility of adenosine Tc-99m tetrofosmin SPECT显示文摘FEOLA M BIGGI A RIBICHINI F 2002Clin Nucl Med2002,27,7:1
14Plasma lipoprotein(a) is not a predictor for restenosis after elective high-pressure coronary stenting显示文摘Ribichini F Steffenino G Dellavalle A 1998Circulation1998,98,:1
15Analysis of right electrocardiographic leads in 195 normal subjects 显示文摘Feola M Ribichini F Gallone G 1994G Ital Cardiol1994,24,4:1
16Comparison of frequen- cy of insulin resistance after coronary stenting in patients with type 2 diabetes mellitus with versus without coronary resteno- sis 显示文摘Feola M Ribichini F Ferrero V 2004Am Cardiol2004,94,6:1
17comparison of frequency of insulin resistance after coronary stenting in patients with type 2 diabetes mellitus with versus without coronary restenosis显示文摘Feola M Ribichini F Ferrero V 2004Am J Cardiol2004,94,6:1
18Implications of new ESC/EACTS guidelines on myocardial revascularization for patients with multivessel coronary artery disease显示文摘Ribichini F Taggart D 2011Eur J Cardiothorac Surg2011,39,5:1
19Association study of the I/D polymorphism and plasma angiotensin-converting enzyme(ACE)as risk factors for stent restenosis显示文摘Ribichini F Ferrero V Matullo G 2004Clinical Science2004,107,:1
20The diagnosis of coro- nary artery disease in hypertensive patients with chest pain and com- plete left bundle branch block : utility of adenosine Tc - 99m tetro- fosmin SPECT显示文摘FEOLA M BIGGI A RIBICHINI F 2002Clin Nucl Med2002,27,7:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费